| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study
|
Kampichit, Sirinya
|
|
|
46 |
2 |
p. 401-410
|
artikel
|
| 2 |
A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic
|
Yap, Meng
|
|
|
46 |
2 |
p. 522-528
|
artikel
|
| 3 |
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases
|
Takeda, Tatsuaki
|
|
|
46 |
2 |
p. 536-541
|
artikel
|
| 4 |
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions
|
Murry, Logan T.
|
|
|
46 |
2 |
p. 542-547
|
artikel
|
| 5 |
Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences
|
Schackmann, Laura
|
|
|
46 |
2 |
p. 439-450
|
artikel
|
| 6 |
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study
|
Tsutsumi, Takezo
|
|
|
46 |
2 |
p. 421-428
|
artikel
|
| 7 |
Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial
|
Sakthong, Phantipa
|
|
|
46 |
2 |
p. 463-470
|
artikel
|
| 8 |
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis
|
Cui, Yuying
|
|
|
46 |
2 |
p. 555-557
|
artikel
|
| 9 |
Correction: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy
|
Wirth, Francesca
|
|
|
46 |
2 |
p. 558
|
artikel
|
| 10 |
Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
|
Zhang, Sha
|
|
|
46 |
2 |
p. 471-479
|
artikel
|
| 11 |
Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach
|
Canning, Martin Luke
|
|
|
46 |
2 |
p. 451-462
|
artikel
|
| 12 |
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study
|
Castel-Branco, M. Margarida
|
|
|
46 |
2 |
p. 411-420
|
artikel
|
| 13 |
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’
|
Scott, Michael
|
|
|
46 |
2 |
p. 355-356
|
artikel
|
| 14 |
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China
|
Zhang, Pei
|
|
|
46 |
2 |
p. 429-438
|
artikel
|
| 15 |
Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system
|
Zhao, Yibei
|
|
|
46 |
2 |
p. 480-487
|
artikel
|
| 16 |
Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis
|
Jermini, Mégane
|
|
|
46 |
2 |
p. 496-505
|
artikel
|
| 17 |
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
|
McCall, Kenneth L.
|
|
|
46 |
2 |
p. 515-521
|
artikel
|
| 18 |
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation
|
Ledwidge, Mark
|
|
|
46 |
2 |
p. 390-400
|
artikel
|
| 19 |
Pharmacists working in residential aged care: a survey of pharmacist interest and perceived preparedness
|
Cross, Amanda J.
|
|
|
46 |
2 |
p. 506-514
|
artikel
|
| 20 |
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
|
Tobaiqy, Mansour
|
|
|
46 |
2 |
p. 488-495
|
artikel
|
| 21 |
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
|
Díaz Acedo, Rocío
|
|
|
46 |
2 |
p. 382-389
|
artikel
|
| 22 |
Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study
|
Savickas, V.
|
|
|
46 |
2 |
p. 529-535
|
artikel
|
| 23 |
The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies
|
Alves, Carlos
|
|
|
46 |
2 |
p. 357-367
|
artikel
|
| 24 |
The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review
|
Tobaiqy, Mansour
|
|
|
46 |
2 |
p. 368-381
|
artikel
|
| 25 |
Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy
|
Wirth, Francesca
|
|
|
46 |
2 |
p. 548-554
|
artikel
|
Tijdschrift beschrijving